The American Academy of Pediatrics (AAP) Committee on the Fetus and Newborn
recommends referral of all high-risk infants to follow up programs after discharge. 1 High-risk …

In this review, we focus on prenatal opioid exposure (POE) given the significant concern for
the mental health outcomes of children with parents affected by opioid use disorder (OUD) in …

Objective The practice of rooming-in for opioid-dependent infants was introduced as the
standard of care at our hospital following a pilot study which demonstrated that such infants …

Chronic intrauterine exposure to psychoactive drugs often results in neonatal opioid
withdrawal syndrome (NOWS). When nonpharmacologic measures are insufficient in …

The substantial lag in medicine between the generation of new evidence and the
implementation of that evidence in routine clinical care has been well-documented. 1 In …

OBJECTIVES: The Modified Finnegan Neonatal Abstinence Scoring System (M-FNASS) and
the newer Eat, Sleep, and Console (ESC) model guide the clinical management of neonatal …

Background The aim of this study was to identify genetic variants associated with NAS
through a genome-wide association study (GWAS) and estimate a Polygenic Risk Score …

BACKGROUND AND OBJECTIVE Methadone and morphine are commonly administered
medications for neonatal opioid withdrawal syndrome (NOWS). Infants are increasingly …

OBJECTIVE Many infants with neonatal opioid withdrawal syndrome (NOWS) from prenatal
exposure to opioids require transfer to a pediatric inpatient unit for medication weaning. The …

Objective Identify factors associated with the need for pharmacologic therapy (PT) among
opioid exposed newborn (OENs). Study design Retrospective analysis of a statewide …